These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4089215)

  • 21. Atherogenic lipoprotein constellation.
    Mordasini R; Riesen WF
    Horm Metab Res Suppl; 1988; 19():16-8. PubMed ID: 3069689
    [No Abstract]   [Full Text] [Related]  

  • 22. [Differential use of apolipoproteins and lipoproteins as discriminators for atherogenic risk].
    Mertz DP; Göhmann E; Ostertag J
    Med Welt; 1981 Oct; 32(43):1611-5. PubMed ID: 7300661
    [No Abstract]   [Full Text] [Related]  

  • 23. Alcohol, lipoproteins, and coronary heart disease.
    Barboriak JJ; Menahan LA
    Heart Lung; 1979; 8(4):736-40. PubMed ID: 256561
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lipids and arteriosclerosis].
    Carmena R
    Rev Clin Esp; 1973 Aug; 130(3):181-94. PubMed ID: 4201566
    [No Abstract]   [Full Text] [Related]  

  • 25. [Plasma lipoproteins and apolipoproteins. Value of their determination in the detection of coronary atherosclerosis. Comparison with data supplied by coronarography].
    Fruchart JC; Bertrand M; Parra H; Gentilini JL; Boniface B; Boniface M
    Nouv Presse Med; 1982 Nov; 11(47):3491-4. PubMed ID: 6818524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of heparin on plasmatic lipoproteins in patients with coronary arteriosclerosis].
    Babei E; Cristea E
    Stud Cercet Med Interna; 1969; 10(6):537-46. PubMed ID: 5370610
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hyperlipoproteinemia. A risk factor in peripheral-arterial and coronary occlusive disease].
    Schwartzkopff W; Thonig S; Sorge F; Hoffmann H; Krüger B; Diehl HJ; Sonderkamp H
    Arzneimittelforschung; 1972 Oct; 22(10):1811-5. PubMed ID: 4678570
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of the complex method of Il'k, Dodik and Iovanovich for diagnosis of humoral lipid disorders in coronary atherosclerosis].
    Fomina LF; Sulava SG; Sulava PV
    Ter Arkh; 1968 Jun; 40(6):61-3. PubMed ID: 5739211
    [No Abstract]   [Full Text] [Related]  

  • 29. [The lipid fractions studied by means of electrophoresis as a screening test of atherosclerosis (author's transl)].
    Diakowski J; Kaliciński A; Proniewska W; Nowak W
    Przegl Lek; 1978; 35(4-5):446-7. PubMed ID: 693994
    [No Abstract]   [Full Text] [Related]  

  • 30. [Peculiarities of protein lipid metabolism and coronary circulation in persons suffering from chronic alcoholism].
    Dziak VN; Borovskiĭ PA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(4):590-2. PubMed ID: 5723687
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interrelation of diabetes mellitus, atherosclerosis and ischemic heart disease].
    Bodnar PN; Donish RM; Pristupiuk AM
    Ter Arkh; 1984; 56(10):88-92. PubMed ID: 6523367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
    Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in serum cholesterol and prebeta-lipoproteins in patients with ischemic heart disease].
    Voslárová Z; Kucerová L; Papezová R
    Sb Lek; 1973 Aug; 75(8):251-6. PubMed ID: 4731467
    [No Abstract]   [Full Text] [Related]  

  • 34. [Multidirectional effects of exercise of various type and intensity on lipid transport system of blood in healthy subjects and patients with coronary heart disease].
    Aronov DM; Bubnov MG; Perova NV; Bondarenko IZ
    Ter Arkh; 2005; 77(9):43-9. PubMed ID: 16281489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoproteins: significance for lipid metabolism and for diagnosis of atherosclerotic disease.
    Kostner GM; Wurm H; Zechner R; Pilger E; Dieplinger H
    Prog Clin Biol Res; 1985; 188():67-77. PubMed ID: 4059260
    [No Abstract]   [Full Text] [Related]  

  • 36. [Apolipoproteins and coronary heart disease].
    Beigl Y; Green P; Lurie Y
    Harefuah; 1987 Apr; 112(8):405-7. PubMed ID: 3315898
    [No Abstract]   [Full Text] [Related]  

  • 37. Lipoproteins, coronary heart disease, and atherosclerosis.
    GOFMAN JW; GLAZIER F; TAMPLIN A; STRISOWER B; DE LALLA O
    Physiol Rev; 1954 Jul; 34(3):589-607. PubMed ID: 13185756
    [No Abstract]   [Full Text] [Related]  

  • 38. High-density lipoproteins in human health and disease.
    Glomset JA
    Adv Intern Med; 1980; 25():91-116. PubMed ID: 6987852
    [No Abstract]   [Full Text] [Related]  

  • 39. Apolipoproteins and risk of coronary heart disease.
    Connelly PW
    CMAJ; 1991 May; 144(10):1277. PubMed ID: 2025824
    [No Abstract]   [Full Text] [Related]  

  • 40. [Value of apolipoprotein B determination in evaluation of atherogenic risk].
    Messaoudia Y
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):217-20. PubMed ID: 7181567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.